Apr 14, 2026 07:08AM
Feb 19, 2026 04:01PM
Jan 16, 2026 01:20PM
Jan 14, 2026 06:48AM
Jan 13, 2026 01:24PM
Jan 13, 2026 01:24PM
Jan 13, 2026 07:27AM Travere Therapeutics (TVTX) Reiterated at Hold by Stifel After FDA Asks for More Info
Jan 13, 2026 04:57AM
Jan 12, 2026 05:00PM
Jan 12, 2026 05:00PM
Dec 24, 2025 11:54AM
Oct 30, 2025 04:01PM
Sep 11, 2025 06:48AM
Sep 10, 2025 10:30AM Jefferies on Travere Therapeutics (TVTX): 'AdCom Cancellation Clear Positive In Our View Setting Stage For Likely Approval'
Sep 10, 2025 10:11AM
Sep 10, 2025 09:58AM
Sep 10, 2025 07:01AM
Sep 10, 2025 07:01AM
Aug 27, 2025 05:09PM
Aug 27, 2025 05:09PM
Aug 7, 2025 10:06AM Travere Therapeutics (TVTX) PT Lowered to $20 at Stifel
Aug 6, 2025 04:01PM
Jun 11, 2025 06:19AM
Jun 11, 2025 04:58AM
May 16, 2025 09:24AM
May 16, 2025 04:20AM
May 15, 2025 04:22PM
May 15, 2025 04:05PM Travere Therapeutics Announces FDA Acceptance of sNDA for FILSPARI® (sparsentan) in FSGS
May 1, 2025 04:01PM
Apr 23, 2025 09:40AM
Mar 17, 2025 07:01AM
Mar 17, 2025 07:01AM
Feb 24, 2025 04:58AM
Feb 20, 2025 04:01PM
Jan 13, 2025 07:00AM Travere Therapeutics Provides Corporate Update and 2025 Outlook
Aug 2, 2024 07:30AM
Aug 1, 2024 04:01PM
May 28, 2024 05:33AM
May 7, 2024 04:00PM
May 6, 2024 04:01PM
Apr 25, 2024 06:40AM
Feb 27, 2024 07:00AM Ligand Reports Fourth Quarter and Full Year 2023 Financial Results
Nov 8, 2023 04:01PM
Aug 8, 2023 04:01PM
May 4, 2023 04:01PM
Jan 9, 2023 07:00AM
Jan 9, 2023 07:00AM
Dec 13, 2022 04:08PM
Oct 27, 2022 04:01PM Travere Therapeutics Reports Third Quarter 2022 Financial Results
Oct 27, 2022 04:01PM

15,430 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All